27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, made a groundbreaking discovery that would later revolutionize diabetes treatment, “Global News” reports.
GLP-1: The Game-Changing Hormone
Drucker discovered a hormone in the human gut, glucagon-like peptide (GLP-1), which regulates blood sugar levels and suppresses appetite. This discovery laid the foundation for the development of popular diabetes drugs such as Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy, according to Global News.
The Gila Monster’s Role
However, the challenge was that GLP-1 quickly disappears from the human body, making drug development difficult. The solution came from an unlikely source: the Gila monster, a venomous lizard native to the southern U.S. This reptile can endure extended periods without food, maintaining stable blood sugar levels, and its venom contains hormones that regulate blood sugar.
From Venom to Ozempic
Drucker and his team found that the Gila monster’s venom contains a hormone, Exendin-4, which shares structural similarities with GLP-1 but does not break down quickly, making it an ideal candidate for a diabetes drug. This hormone was synthesized into a pharmaceutical drug, Exenatide, which became the first approved treatment for Type 2 diabetes in 2005.
Ozempic: A New Generation Drug
Following Exenatide, a new generation of GLP-based drugs emerged, with Ozempic being the most popular. Ozempic mimics the GLP-1 hormone, lowering blood sugar and slowing digestion, making people feel full longer. Drucker has consulted with Novo Nordisk, providing guidance on Ozempic’s development.
Drucker’s Contribution
Drucker’s research has been instrumental in the development of diabetes treatments, earning him several awards, including Israel’s prestigious Wolf Prize for work on diabetes and the 2021 Canada Gairdner International Award. He was also inducted into the Canadian Medical Hall of Fame and appointed Officer of the Order of Canada.
Hi, I am the Benzinga Newsbot! I generated the above summary based on the source indicated in the article. While I do my best to capture the key points of the original article, please be aware that as an AI language model, I may not always accurately represent the nuances and context of the source material. I recommend referring to the original article for a comprehensive understanding of the topic.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!